Pluri (PLUR) Debt Ratio (2021 - 2025)
Pluri (PLUR) posted quarterly Debt Ratio of 0.91 for Q4 2025, up 17.75% year-over-year from 0.77 in Q4 2024, and up 11.02% quarter-over-quarter from 0.82 in Q3 2025.
Pluri (PLUR) Debt Ratio (2021 - 2025) Analysis & Trends
Pluri (PLUR) has reported Debt Ratio for 5 consecutive years, with 0.91 the latest figure, recorded in Q4 2025.
- In Q4 2025, Debt Ratio rose 17.75% year-over-year to 0.91; the TTM figure through Dec 2025 stood at 0.91 (up 17.75% YoY), while the FY2025 annual figure was 0.71, up 16.05% from the prior year.
- Debt Ratio grew to 0.91 in Q4 2025 per PLUR's latest filing, from 0.82 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.91 in Q4 2025 and bottomed at 0.25 in Q2 2021.
- Historically, Debt Ratio has averaged 0.53 across 5 years, with a median of 0.52 in 2023.
- Annual changes were most pronounced in 2024 — Debt Ratio jumped 59.31% — and 2025, when it rose 0.85%.
- Pluri's Debt Ratio stood at 0.29 in 2021, then jumped by 32.65% to 0.38 in 2022, then soared by 55.15% to 0.59 in 2023, then soared by 31.35% to 0.77 in 2024, then rose by 17.75% to 0.91 in 2025.
- Business Quant data shows PLUR's Debt Ratio at 0.91 in Q4 2025, 0.82 in Q3 2025, and 0.71 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.50 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.98 Bn | 53.84 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | 0.47 |
| 10 | Pluri | 15.74 Mn | 3.26 Mn | 86,000.00 | 0.91 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.91 |
| Sep 30, 2025 | 0.82 |
| Jun 30, 2025 | 0.71 |
| Mar 31, 2025 | 0.67 |
| Dec 31, 2024 | 0.77 |
| Sep 30, 2024 | 0.72 |
| Jun 30, 2024 | 0.61 |
| Mar 31, 2024 | 0.66 |
| Dec 31, 2023 | 0.59 |
| Sep 30, 2023 | 0.52 |
| Jun 30, 2023 | 0.46 |
| Mar 31, 2023 | 0.42 |
| Dec 31, 2022 | 0.38 |
| Sep 30, 2022 | 0.35 |
| Jun 30, 2022 | 0.32 |
| Mar 31, 2022 | 0.29 |
| Dec 31, 2021 | 0.29 |
| Sep 30, 2021 | 0.28 |
| Jun 30, 2021 | 0.25 |